Boswellia: Product Forms and How to Choose
Boswellia has moved from Ayurvedic tradition into mainstream joint-support shelves. Yet a capsule of ground resin and a capsule of standardised AKBA extract are very different products. Our editorial team explains the formats, what the evidence says and how to choose sensibly.
What boswellia is and why athletes look at it
Boswellia serrata, often sold as Indian frankincense, is a tree resin with a long history in Ayurvedic practice. Its interest for active people comes from a group of compounds called boswellic acids, which laboratory studies show can influence enzymes involved in inflammatory signalling, notably 5-lipoxygenase.
The compound most often discussed is 3-O-acetyl-11-keto-beta-boswellic acid, usually abbreviated to AKBA. It is considered one of the more active boswellic acids, which is why many modern products advertise their AKBA percentage on the label rather than simply the weight of resin.
In sport, boswellia is typically considered by people with sore joints, older recreational runners and lifters who want something milder than routine painkillers. The clinical evidence mostly comes from people with knee osteoarthritis rather than from healthy athletes, so expectations should be set accordingly.
In the UK, boswellia is sold as a food supplement. That means it is not licensed as a medicine, its claims are restricted under retained nutrition and health claims rules, and quality can vary considerably between brands.
The main product forms on the market
Boswellia supplements look similar on the shelf but differ substantially in what is inside the capsule. The table below summarises the formats you are most likely to encounter.
| Form | What it contains | Strengths | Limitations |
|---|---|---|---|
| Ground resin / gum powder | Whole resin, unstandardised | Inexpensive, closest to traditional use | Boswellic acid content unknown and variable |
| Standardised extract | Typically labelled as a percentage of total boswellic acids | More predictable composition | Total acids do not tell you how much AKBA is present |
| AKBA-enriched extract | Extracts concentrated for AKBA | Used in several published trials | Usually more expensive |
| Lipid or phospholipid complexes | Extract bound to phospholipids or other carriers | Designed to improve absorption | Fewer independent studies |
| Combination joint formulas | Boswellia plus curcumin, glucosamine, collagen etc. | Convenient | Dose of each ingredient often too low |
Topical creams also exist, but evidence for skin application is thin, and most research concerns oral extracts taken for several weeks.
When comparing products, the key question is not "how many milligrams of boswellia" but "how much of which standardised extract", ideally with a stated AKBA content.
Reading the label: what really matters
A well-labelled boswellia product will tell you the botanical species, the part used (gum resin), the extract ratio or standardisation, and the daily amount of extract. Missing species names or vague phrases such as "proprietary blend" are a reason for caution.
- Species: Boswellia serrata is the most studied; other species have a different acid profile.
- Standardisation: look for a percentage of boswellic acids and, preferably, AKBA.
- Dose per day: clinical trials have generally used a few hundred milligrams of extract daily, often split into two doses.
- Testing: third-party testing for contaminants and identity adds confidence.
- Sport certification: athletes subject to testing should prefer batch-tested products from schemes such as Informed Sport.
Boswellic acids are fat-soluble, and absorption is believed to improve when the supplement is taken with a meal containing some fat. This is one practical detail that costs nothing and may help.
Be wary of products that make disease claims, such as curing arthritis. Under UK rules such claims are not permitted for food supplements, so their presence suggests a seller who is not following the regulations.
What the research shows
Most of the clinical evidence comes from randomised trials in adults with knee osteoarthritis. A systematic review and meta-analysis by Yu and colleagues in 2020 concluded that boswellia and its extracts may improve pain and function scores over several weeks, while noting the modest size and quality of many trials.
An earlier trial by Sengupta and colleagues tested an AKBA-enriched extract (5-Loxin) and reported improvements in pain and physical function compared with placebo over 90 days. Such industry-linked studies are useful, but independent replication remains limited.
Laboratory work, including research by Ammon, has described how boswellic acids interact with inflammatory enzymes. These mechanistic findings help explain the interest, but they do not prove clinical benefit by themselves.
There is little direct evidence that boswellia improves athletic performance or speeds recovery from heavy training in healthy people. Its realistic role is as a supporting option for persistent joint discomfort, not as a performance supplement.
Safety and who should be careful
In trials, boswellia extracts have generally been well tolerated. The most commonly reported side effects are gastrointestinal: stomach upset, nausea, acid reflux or loose stools.
Data in pregnancy and breastfeeding are lacking, so it is sensible to avoid it during these periods. People with known allergy to the resin or to related plants should also avoid it.
Because boswellia acts on inflammatory pathways, anyone taking anticoagulants, antiplatelet drugs or immunosuppressants should discuss it with a pharmacist first. Interaction data are incomplete, which is a reason for caution rather than reassurance.
Persistent joint pain, swelling, locking or instability needs assessment, ideally by a GP or physiotherapist. A supplement should not delay diagnosis of an injury that may need specific treatment.
Editorial conclusions
For most people interested in boswellia, a standardised extract with a declared AKBA content, taken with food, is the most rational choice. Unstandardised powder makes it impossible to know what you are getting, while combination products often underdose each component.
Expectations should be realistic: the evidence points to modest benefits for joint discomfort over weeks, not to faster recovery or better performance in healthy athletes.
Choose products with clear labelling and independent testing, and talk to a pharmacist if you take regular medication.
You may also find it useful to read our pieces on curcumin and its absorption, on collagen for tendons and joints, and on how to read supplement labels.
References
- Yu G, Xiang W, Zhang T, Zeng L, Yang K, Li J. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complement Med Ther. 2020;20(1):225.
- Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008;10(4):R85.
- Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: a randomized double blind placebo controlled trial. Phytomedicine. 2003;10(1):3–7.
- Ammon HP. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006;72(12):1100–1116.
- Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2011;73(3):255–261.
- https://anabolicsteroid-usa.com/
